RESEARCH-USE BIOSIMILAR ANTIBODY
Cosibelimab
Monoclonal antibody · IgG1
Cosibelimab (CK-301) is a high-affinity, fully human PD-L1-blocking monoclonal antibody that binds PD-L1 and blocks its interaction with PD-1. Cosibelimab exhibits antitumor efficacy.
TARGETPDL1
YMonoclonal antibody
CATALOGSC-BS-660
CATALOG NUMBERSC-BS-660
MOLECULAR WEIGHTApprox. 144.64 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Cosibelimab (CK-301) is a high-affinity, fully human PD-L1-blocking monoclonal antibody that binds PD-L1 and blocks its interaction with PD-1. Cosibelimab exhibits antitumor efficacy.
Cosibelimab is a recombinant research-use antibody directed against PDL1.